RecruitingGlaucoma, Open-Angle
Travoprost Intraocular Implant + iStent Infinite
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Sponsor: Glaukos Corporation
You may qualify if…
- ✓ diagnosis of open-angle glaucoma or ocular hypertension
- ✓ qualifying IOP in the study eye
You may not qualify if…
- ✕ unmedicated (washed out) IOP of \>36 mmHg in the study eye
- ✕ hypersensitivity to travoprost or any other components of the travoprost intraocular implant
- ✕ vertical cup/disc ratio \> 0.8 in the study eye
- ✕ best spectacle corrected visual acuity of worse than 20/80 in either eye
- ✕ any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
Where it's recruiting
Oklahoma
Oklahoma City
Source: ClinicalTrials.gov · NCT06066645 · last updated 2026-06-02